These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15715721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system.
    Wahl RU, Lütticken R, Stanzel S, van der Linden M, Reinert RR.
    Clin Microbiol Infect; 2007 Dec; 13(12):1173-8. PubMed ID: 17850344
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Invasive Lancefield group A streptococcal infections in the Netherlands].
    Vlaminckx BJ, Mascini EM, Schellekens JF.
    Ned Tijdschr Geneeskd; 2007 Jul 28; 151(30):1669-73. PubMed ID: 17725254
    [Abstract] [Full Text] [Related]

  • 7. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region.
    Laupland KB, Ross T, Church DL, Gregson DB.
    Clin Microbiol Infect; 2006 Mar 28; 12(3):224-30. PubMed ID: 16451408
    [Abstract] [Full Text] [Related]

  • 8. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.
    Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE.
    N Engl J Med; 1996 Aug 22; 335(8):547-54. PubMed ID: 8684408
    [Abstract] [Full Text] [Related]

  • 9. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.
    Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinhøj P, Konradsen HB.
    J Clin Microbiol; 2005 Jul 22; 43(7):3101-9. PubMed ID: 16000420
    [Abstract] [Full Text] [Related]

  • 10. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.
    Mascini EM, Jansze M, Schellekens JF, Musser JM, Faber JA, Verhoef-Verhage LA, Schouls L, van Leeuwen WJ, Verhoef J, van Dijk H.
    J Infect Dis; 2000 Feb 22; 181(2):631-8. PubMed ID: 10669348
    [Abstract] [Full Text] [Related]

  • 11. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects.
    Ekelund K, Skinhøj P, Madsen J, Konradsen HB.
    Clin Microbiol Infect; 2005 Jul 22; 11(7):569-76. PubMed ID: 15966976
    [Abstract] [Full Text] [Related]

  • 12. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.
    O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C, Active Bacterial Core Surveillance Team.
    Clin Infect Dis; 2007 Oct 01; 45(7):853-62. PubMed ID: 17806049
    [Abstract] [Full Text] [Related]

  • 13. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections.
    Rogers S, Commons R, Danchin MH, Selvaraj G, Kelpie L, Curtis N, Robins-Browne R, Carapetis JR.
    J Infect Dis; 2007 Jun 01; 195(11):1625-33. PubMed ID: 17471432
    [Abstract] [Full Text] [Related]

  • 14. Prospective surveillance of streptococcal sore throat in a tropical country.
    Steer AC, Jenney AW, Kado J, Good MF, Batzloff M, Magor G, Ritika R, Mulholland KE, Carapetis JR.
    Pediatr Infect Dis J; 2009 Jun 01; 28(6):477-82. PubMed ID: 19483515
    [Abstract] [Full Text] [Related]

  • 15. Group A streptococcal bacteremia: outcome and prognostic factors.
    Vallalta Morales M, Soriano Navarro CJ, Salavert Lletí M, Montero Alonso M, Pérez Bellés C, López Aldeguer J, Otero MC, Gobernado Serrano M.
    Rev Esp Quimioter; 2006 Dec 01; 19(4):367-75. PubMed ID: 17235407
    [Abstract] [Full Text] [Related]

  • 16. Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996.
    Vlaminckx B, van Pelt W, Schouls L, van Silfhout A, Elzenaar C, Mascini E, Verhoef J, Schellekens J.
    Eur J Clin Microbiol Infect Dis; 2004 Jun 01; 23(6):434-44. PubMed ID: 15164257
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.
    O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A.
    Clin Infect Dis; 2002 Aug 01; 35(3):268-76. PubMed ID: 12115092
    [Abstract] [Full Text] [Related]

  • 18. Epidemic of group A Streptococcus M/emm59 causing invasive disease in Canada.
    Tyrrell GJ, Lovgren M, St Jean T, Hoang L, Patrick DM, Horsman G, Van Caeseele P, Sieswerda LE, McGeer A, Laurence RA, Bourgault AM, Low DE.
    Clin Infect Dis; 2010 Dec 01; 51(11):1290-7. PubMed ID: 21034198
    [Abstract] [Full Text] [Related]

  • 19. Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates.
    Eriksson BK, Norgren M, McGregor K, Spratt BG, Normark BH.
    Clin Infect Dis; 2003 Nov 01; 37(9):1189-93. PubMed ID: 14557963
    [Abstract] [Full Text] [Related]

  • 20. Invasive group A streptococcal disease in children in Queensland.
    Whitehead BD, Smith HV, Nourse C.
    Epidemiol Infect; 2011 Apr 01; 139(4):623-8. PubMed ID: 20609283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.